Study aimed to soothe rash from cancer drugs, but never started
NCT ID NCT04731259
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 32 times
Summary
This study was designed to see if a cream called ATR-04 could safely reduce a common, painful rash on the face caused by certain cancer drugs. It planned to include about 60 adults with cancer who were about to start those drugs. However, the study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPIDERMAL GROWTH FACTOR are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.